Skip to main content
. 2019 Feb 1;3(3):333–338. doi: 10.1182/bloodadvances.2018023051

Table 1.

Univariate and multivariate analysis–modeled results: death resulting from HMs at home or in hospice facility (vs death in another location)

Univariate analysis Multivariate analysis
OR (95% CI) P OR (95% CI) P
All cancers (HMs and solid tumors)
 Year of death (continuous variable) 1.058 (1.058-1.058) <.001 1.047 (1.046-1.047) <.001
 Age, y
  Age (continuous variable) 0.997 (0.0997-0.998) <.001 <.001
  0-39 1.000 1.000
  40-64 1.366 (1.351-1.381) <.001 1.095 (1.077-1.112) <.001
  ≥65 1.295 (1.281-1.309) <.001 1.050 (1.034-1.067) <.001
 Sex
  Female (reference) 1.000 1.000
  Male 1.030 (1.027-1.033) <.001 0.930 (0.926-0.934) <.001
 Marital status* <.001 <.001
  Single (reference) 1.000 1.000
  Married 2.027 (2.058-2.082) <.001 1.997 (1.982-2.013) <.001
  Divorced/separated 1.361 (1.352-1.370) <.001 1.284 (1.273-1.296) <.001
  Widowed 1.411 (1.403-1.419) <.001 1.388 (1.376-1.400) <.001
 Education level <.001
  Some high school or less (reference) 1.000 <.001 1.000
  High school graduate (≥4 y) 1.047 (1.042-1.052) <.001 0.976 (0.970-0.981) <.001
  Some college/associates degree 1.174 (1.167-1.181) <.001 1.068 (1.061-1.076) <.001
  College graduate (≥4 y) 1.163 (1.155-1.171) <.001 1.055 (1.047-1.063) <.001
  Advanced degree 1.206 (1.196-1.216) <.001 1.092 (1.082-1.102) <.001
 Race <.001 <.001
  White (reference) 1.000 1.000
  Black or African American 0.669 (0.666-0.672) <.001 0.693 (0.731-0.757) <.001
  Asian or Pacific Islander 0.776 (0.768-0.783) <.001 0.636 (0.629-0.644) <.001
  American Indian or Alaska Native 0.888 (0.869-0.906) <.001 0.859 (0.836-0.883) <.001
 Ethnicity
  Non-Hispanic (reference) 1.000 1.000
  Hispanic 1.089 (1.082-1.096) <.001 0.954 (0.946-0.962) <.001
 Primary cancer diagnosis
  Solid tumor (reference) 1.000 1.000
  HM 0.570 (0.567-0.573) <.001 0.547 (0.543-0.551) <.001
HMs only
 Year of death (continuous variable) 1.058 (1.058-1.058) <.001 1.053 (1.051-1.055) <.001
 Age, y
  Age (continuous variable) 0.997 (0.0997-0.998) <.001 <.001
  0-39 1.000 1.000
  40-64 1.366 (1.351-1.381) <.001 1.335 (1.281-1.390) <.001
  ≥65 1.295 (1.281-1.309) <.001 1.888 (1.814-1.965) <.001
 Sex
  Female (reference) 1.000 1.000
  Male 1.030 (1.027-1.033) <.001 0.990 (0.977-1.003) .133
 Marital status* <.001 <.001
  Single (reference) 1.000 1.000
  Married 2.027 (2.058-2.082) <.001 1.612 (1.570-1.655) <.001
  Divorced/separated 1.361 (1.352-1.370) <.001 1.241 (1.204-1.280) <.001
  Widowed 1.411 (1.403-1.419) <.001 1.417 (1.377-1.458) <.001
 Education level <.001 <.001
  Some high school or less (reference) 1.000 1.000
  High school graduate (≥4 y) 1.047 (1.042-1.052) <.001 0.969 (0.952-0.986) <.001
  Some college/associates degree 1.174 (1.167-1.181) <.001 1.030 (1.010-1.051) .004
  College graduate (≥4 y) 1.163 (1.155-1.171) <.001 0.984 (0.963-1.007) .174
  Advanced degree 1.206 (1.196-1.216) <.001 1.000 (0.974-1.026) .991
 Race <.001 <.001
  White (reference) 1.000 1.000
  Black or African American 0.669 (0.666-0.672) <.001 0.680 (0.664-0.695) <.001
  Asian or Pacific Islander 0.776 (0.768-0.783) <.001 0.575 (0.552-0.599) <.001
  American Indian or Alaska Native 0.888 (0.869-0.906) <.001 0.884 (0.804-0.972) .011
 Ethnicity
  Non-Hispanic (reference) 1.000 1.000
  Hispanic 1.089 (1.082-1.096) <.001 0.843 (0.824-0.864) <.001
 Primary cancer diagnosis <.001 <.001
  Acute leukemia (reference) 1.000 1.000
  Chronic leukemia 0.887 (0.870-0.904) <.001 0.829 (0.810-0.849) <.001
  Aggressive lymphoma 1.244 (1.209-1.279) <.001 1.141 (1.103-1.180) <.001
  Nonaggressive lymphoma 1.077 (1.044-1.110) <.001 1.181 (1.136-1.227) <.001
  Myeloma 1.325 (1.305-1.344) <.001 1.338 (1.313-1.364) <.001
  Other leukemia/lymphoma 1.155 (1.140-1.169) <.001 1.133 (1.115-1.152) <.001
*

Martial status is unknown in 0.7% of the 2003-2015 data file.

Education level is unknown in 38.5% of the 2003-2015 data file.

Acute leukemia includes acute myeloid and acute lymphocytic leukemias; chronic leukemia includes chronic myeloid and chronic lymphocytic leukemias; aggressive lymphoma includes diffuse large B-cell and Burkitt’s lymphomas; nonaggressive lymphoma includes Hodgkin disease and follicular lymphoma; and myeloma includes multiple myeloma, plasma cell leukemia, and plasmacytoma.